摘要
目的比较帕罗西汀联合生物反馈放松疗法治疗躯体形式障碍的临床疗效。方法将50例躯体形式障碍患者随机分为研究组(帕罗西汀联合生物反馈放松疗法治疗)25例与对照组(单用帕罗西汀治疗)25例,于治疗前及治疗后第1、2、4周末用症状自评量表(SCL—90)躯体化因子分、汉密尔顿抑郁量表(HAM D)评定疗效。结果治疗后2组SCL—90躯体化因子分(t=2.38,P<0.01)、HAM D总分(t=2.35,P<0.01)较治疗前明显减少,差异有统计学意义。4周末有效率研究组80%,对照组52%,差异有统计学意义(P<0.01)。从第1周末开始,研究组SCL—90中躯体化因子分即明显低于对照组(t=2.51,P<0.05)。第2周末开始,研究组HAM D总分亦明显低于对照组(t=2.54,P<0.05)。结论帕罗西汀联合生物反馈比单用帕罗西汀治疗躯体形式障碍起效更快,疗效更佳。
Objective To study the clinical effects of Paroxetine combined with biofeedback relaxation therapy in the treatment of somatoform disorder.Methods A total of 50 patients with somatoform disorder were randomly divided into study group（Paroxetine combined with biofeedback relaxation therapy） and control group（single Paroxetine）for the treatment of 4 weeks. They were assessed with the smatization factor of SCL-90 and HAMD before and 1st,2nd,4th weeken of the treatment.Results The factor scores of somatization in SCL-90（t=2.38,P0.01） and total scores of HAMD（t=2.35,P0.01） in two groups were significantly decreased after treatment,and there were significant differences between two groups.At the end of 4th week,effective rates of study group and control group were 80% and 52% respectively,which showed a significant difference（P0.01）.The factor somatization scores of in study group were significantly lower than those in control groups at the end of 1st week after treatment（t=2.51,P0.05）,and total scores of HAMD in study group were also significantly lower than those in control group at the end of 2nd week（t=2.54,P0.05）.Conclusion Paroxetine combined with biofeedback relaxation therapy will take effects fast and has good efficacy in the treatment of somatoform disorders.
出处
《中国健康心理学杂志》
2011年第6期646-647,共2页
China Journal of Health Psychology
